Regulation of bradykinin-induced cyclic AMP response by quinacrine and prostaglandin E2and F2αin human synovial fibroblasts
✍ Scribed by John V. Fahey; David S. Newcombe
- Publisher
- Springer
- Year
- 1979
- Tongue
- English
- Weight
- 448 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0360-3997
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
In a recent communication, we demonstrated that prostaglandin E 2 (PGE 2 ) lowers basal while it ablates interleukin-1( (IL-1) and transforming growth factor- (TGF) upregulated lysyl oxidase (LO) mRNA levels. Correspondingly, PGE 2 increases cyclooxygenase-1 (COX1) mRNA in diploid, human embryo
## Objective: To investigate the effects of the antiinflammatory cytokines interleukin-4 (il-4), il-10, and il-13 on tumor necrosis factor alpha (tnfalpha)-induced prostaglandin e2 (pge2) release in the cellular signaling cascade on human osteoarthritis (oa) synovial fibroblasts. ## Methods: Huma
The degradative effects of interleukin-1 (IL-1) on the extracellular matrix of connective tissue are mediated primarily by metalloproteinases and prostaglandins. Clinical observations suggest that these effects can be prevented, to some extent, by the use of non-steroidal anti-inflammatory drugs. We
Collagenase-3 (matrix metalloproteinase, MMP-13) plays an important role in the degradation of cartilage in pathologic conditions. MMP-13 is elevated in joint tissues in both rheumatoid arthritis (RA) and osteoarthritis (OA). In addition, inflammation-stimulated synovial fibroblasts are able to rele